ViroSure

Executive Summary

ViroSure is a Vienna-based contract research organization founded in 2010, specializing in biosafety testing for biopharmaceuticals, advanced therapies, and novel foods. The company's core expertise includes viral and prion clearance studies, GMP-compliant biosafety testing, and regulatory consultancy. With the global biopharma market expanding and increasing regulatory scrutiny on product safety, ViroSure is well-positioned to serve a growing client base. The company's focus on high-quality, specialized testing services differentiates it from larger, more generalized CROs. As a private entity, ViroSure benefits from agility and deep technical expertise, which are critical in the niche field of viral safety. The company's established reputation and location in Vienna, a European biotech hub, provide access to a skilled workforce and proximity to key clients. ViroSure's business model relies on recurring projects from biopharma sponsors, and its success is tied to the overall health of the biotech ecosystem.

Upcoming Catalysts (preview)

• Q1 2027Expansion into novel food safety testing services60% success
• Q3 2026Strategic partnership with a top-20 biopharma company for viral clearance studies50% success
• Q4 2026Accreditation for new GMP testing standards (e.g., ICH Q5A(R2) implementation)70% success